06. BAB V - LAMPIRAN.doc

Embed Size (px)

Citation preview

BAB VPENUTUPKesimpulan Variasi konsentrasi CMC-Na dan PVP K-30 dalam formulasi bukal patch salbutamol sulfat tidak berpengaruh terhadap keseragaman bobot, folding endurance, surface pH dan keseragaman kandungan. Tetapi berpengaruh terhadap persentase swelling index dimana peningkatan konsentrasi PVP K-30 sampai 20% dapat meningkatkan persentase swelling index tetapi mengalami penurunan pada konsentrasi PVP K-30 sebesar 30%. Peningkatan konsentrasi PVP K-30 sampai 20% dapat memperbaiki dan meningkatkan pelepasan Salbutamol Sulfat dari patch tetapi mengalami penurunan pada konsentrasi PVP K-30 sebesar 30%. Pelepasan obat mengikuti kinetika orde nol dengan mekanisme pelepasan dikontrol oleh difusi melalui matriks dengan mengikuti mekanisme difusi Fick. Saran Perlu dilakukan uji in vivo sehingga dapat diketahui bioavailabilitas sediaan bukal patch salbutamol sulfat dan dapat dibuat korelasi in vivo dan in vitro. Perlu dilakukan penelitian lebih lanjut mengenai optimasi perbandingan penggunaan CMC-Na dan PVP K-30 untuk mendapatkan pelepasan obat yang baik. 80DAFTAR PUSTAKAAnonim. 2000. The United States Pharmacopeia and National Formulary.Washington DC. 54-55Ajeet, Singh B, Juneja R. 2012. Recent Findings in Concern to Buccal Patches : a Review. International Journal of Current Pharmaceutical Research 4 (1) : 12-17.Anggraini D. 2011. Formulasi dan Uji In vitro Granul Mukoadhesif Salbutamol Sulfat Menggunakan Kombinasi Polimer carbopol 940P dan Hidroksipropil Selulosa [skripsi]. Padang : Universitas Andalas. Hlm 8-9.Arya RK, Chaurasia H, Bharadwaj P, Garud N, Palani S. 2011. Development and Evaluation of Mucoadhesive Buccal Tablets of Salbutamol Sulphate.International Research Journal of Pharmacy 2 (1) : 159-162.Astuti P, Yunus F, Antariksa B, Ratnawati. 2011. Prevalensi dan Gejala Klinis Obstructive Sleep Apnea (OSA) pada Pasien Asma. Journal Indonesian Medical Association 61 : 2.Bankar PH, Gaikwad PD, Pawar SP. 2011. Novel Sustained Release Drug Delivery System : Review. International Journal of Pharmaceutical Research & Development 3(12) : hlm 1-14.Chang HS, Robinson JR. 1987. Bioadhesive Polymers as Platforms for Oral Controlled Drug Delivery II Synthesis and Evaluation of some Swelling water Insoluble Bioadhesive Polymers. Journal of Pharmaceutical Science. 74:399-405.Departemen Kesehatan RI. 1979. Farmakope Indonesia. Ed ke-III. Jakarta. 285-286Departemen Kesehatan RI. 1995. Farmakope Indonesia. Ed ke-IV. Jakarta. 355-356Gandhi PA, Patel MR, Patel KR, Patel NM. 2011. A Review Article on Mucoadhesive Buccal Drug Delivery System. International Journal of Pharmaceutical Research & Development 3(5): 159 173.Gandjar IG, Rahman A. 2007. Kimia Farmasi Analisis. Pustaka pelajar. Jakarta.Ilavarasan P, Ezhumalai K, Rajalakshmi AN. 2011. Buccal Patches as Emerging Trend. International Journal of Pharmacy & Technology 3 : 973-986.8182Jyotsana M, Sagar B, Mahesh D. 2010. Mucosal Drug Delivery System. International Journal of Research in Ayurveda & Pharmacy 1 (1) : 63-70.Kaul M, Verma S, Rawat A, Saini S. 2011. An Overview on Buccal Drug Delivery System. International Journal of Pharmaceutical Sciences and Research 2(6) : 1303-1321.Khairnar GA, Sayyad FJ. 2010. Development of Buccal Drug Delivery System. International Journal of PharmTech Research 4(8) : 874-883.Khan KA. 1975. The Concept of Dissolution Efficiency. Journal of Pharmaceutical Pharmacol 27 (1) : 48-49.Lachman L, Lieberman HA, Kaning JL. 1994. Teori dan Praktek Farmasi Industri, diterjemahkan oleh Suyatmi. Jilid II. Universitas Indonesia Press.Leeson LJ, Carstensen JT. 1974. Dissolution Technology. Whitlock Press Inc. United states.Lordi NG. 1986. Sustained Release Dosage Form in the Theory and Practice of Industrial Pharmacy. Ed ke-3. Philadelphia : Lea & Febiger. Hlm 430-456.Majid FCN. 2009. Formulasi Patch Mukoadhesif Propranolol Hidroksida: Pengaruh Perbandingan Konsentrasi Natrium Karboksimetilselulosa dan Polivinil Pirolidon Terhadap Sifat Fisik Patch dan Pelepasan obat [skripsi]. Surakarta : Fakultas Farmasi Universitas Muhammadiyah Surakarta.Martindale. 2009. Martindale The Complete Drug Reference. - 36th Edition ed. Pharmaceutical Press. Hlm 793.Modi SA, Gaikwad PD, Bankar VH, Pawar SP. 2011. Sustained Release Drug Delivery System : A Review. International Journal of Pharma Research and Development 2 (12) : 147-160.Mouzam T, Dehgan MHG, Asis S, Sahuji T, Chudiwal P. 2011. Development of a Novel Floating Ring Capsule-Type Dosage Form for Stomach Specific Delivery. Saudi Pharmaceutical Journal. 238-240.Panigrahi L, Pattnaik S, Ghosal SK. 2004. Design and Characterization of Mucoadhesive Buccal Patches of Salbtamol Sulfate. Acta Poloniae Pharmaceutica-Drug Research 61 (5) : 35-360.Patel AR, Patel DA, Chaudhry SV. 2011. Mucoadhesive Buccal Drug Delivery System. International Journal of Pharmacy & Life Sciences 2 (6) : 848-856 848.Patel K, Patel U, Bhimani B, Patel G, Daslaniya D. 2012. Extended Release Oral Drug Delivery System. IJPRBS vol 1 (3) : 1-26.83Patel KV, Patel ND, Dodiya HD, Shelat PK. 2011. Buccal Bioadhesive Drug Delivery System: An Overview. International Journal of Pharmaceutical and Biological Archives 2(2) : 600-609.Patel RS, Poddar SS. 2009. Development and Characterization of Mucoadhesive Buccal Patches of Salbutamol Sulphate. Current Drug Delivery 6 : 140-144.Patel VM, Prajapati BG, Patel MM. 2007. Design and characterization of chitosan-containing mucoadhesive buccal patches of propranolol hydrochloride. Acta Pharma 57 : 6172.Pathan AM, Channawar MA, Bakde BV, DR. Chandewar AV. 2011. Development And In vitro Evaluation of Salbutamol Sulphate Mucoadhesive Buccal Patches. International Journal of Pharmacy and Pharmaceutical Sciences 3 Suppl 2: 39-44.Priya S et al. 2011. Preparation and Evaluation of Buccal Mucoadhesive Patch of Betamethasone Sodium Phosphate for the Treatment of Oral Submucosa Fibrosis. Journal of Chemical and Pharmaceutical research 3 (6) : 56-65.Puratchikody A, Prasanth VV, Mathew ST, Kumar BA. 2011. Buccal Drug Delivery: Past, Present and Future A Review. International Journal of Drug Delivery 3 : 171-184.Puratchikody A, Prasanth VV, Mathew ST, Kumar BA. 2011. Development and Characterization of Mucoadhesive Patches of Salbutamol Sulfate for Unidirectional Buccal Drug Delivery. Acta Pharma 61 : 157170.Rowe RC, Sheskey PJ, Quinn ME, editor. 2009. Handbook of Pharmaceutical Excipients. Ed ke-6. USA : Pharmaceutical Press. Hlm 147-150 ; 291-295 ; 610-614.Roychowdhury S, Gupta R, Saha S. 2011. A Review on Buccal Mucoadhesive Drug Delivery Systems. Indo-Global Journal of Pharmaceutical Sciences 1(3) : 223-233.Sadray S, Honary S, Ebrahimi P, Jafari P, Rezaee S. 2010. Dissolution Profile Comparison : Model Dependent and Model Independent Approaches.International Journal of Pharmaceutical and Bio Sciences 1 (2) : 1-8Satyabrata et al. 2010. Design and evaluation of methotrexate buccal mucoadhesive patches. International Journal of Pharmaceutical Biomedic and Sciences 1(2) : 31-36Shargel L, Wu-Pong S, Yu, A.B.C. 2005. Applied Biopharmaceutics and Pharmacokinetics. Ed ke-5. Appleton dan Lange, United States. Hlm 97-113, 132, 735.84Shojaei AH, Chang RK, Guo X, Burnside BA, Couch RA. 2001. Systemic Drug Delivery via the Buccal Mucosal Route. Pharmaceutical Technology. Hlm 70-81.Singhvi G, Singh M. 2011. Review : In-Vitro Drug Release Characterization Models. International Journal of Pharmaceutical Studies and Research II Issue I : 77-84.Siregar, C.J.P. dan S. Wikarsa. 2010. Teknologi Farmasi Sediaan Tablet Dasar-Dasar Praktis. Kedokteran EGC. Jakarta. Hlm 159-160Suroyah E. 2012. Pengaruh Perbedaan Kadar Propilen Glikol sebagai Permeation Enhancer dalam Formulasi dan Evaluasi carvedilol Bukal Mukoadhesif patch [skripsi]. Jogjakarta : Fakultas Farmasi Universitas Gadjah Mada. Hlm 24-25.Tan HJ, Kirana R. 2002. Obat-obat penting. Jakarta : Elex Media Komputindo. Hlm 600-613.Venkatalakshmi R, Sudhakar Y, Chetty CM, Sasikala C, Varma MM. 2012. Buccal Drug Delivery Using Adhesive Polymeric Patches. International Journal of Pharmaceutical Study and Research 3(1) : 35-41.Walker R, Edwards C, editor. 2002. Clinical Pharmacy and Therapeutics. Ed ke-3. USA: Churcil Livingstone Elsevier. Hlm 375-379.85Lampiran 1. Data hasil keseragaman bobot.Formula patch (mg)Formula 1Formula 2Formula 3Formula 4Formula 5(Kontrol)(10:0)(9:1)(8:2)(7:3)109,0121,5116,2110,1102,7113,6121,8116,6110,9102,7119,2125,1116,8111,2104,6121,0126,8117,1112,9104,6121,8126,9117,1113,1105,3122,2127,1118,0116,2105,3123,6127,7118,2117,3105,6124,0128,8119,0118,9106,8124,4129,4119,7119,7107,0124,8130,6120,3120,0107,1124,8130,8120,8120,4107,3124,8131,6120,8121,9107,8125,2132,7121,2122,2107,8125,8133,6121,8122,2108,0126,8134,7123,3123,5108,1127,8135,1123,4123,8108,5128,4136,7123,8123,8108,7129,3138,0124,0124,0108,7130,6139,5124,3124,1109,0130,8139,5124,8124,4109,4Rata-rata123,9130,895120,36119,03106,75SD5,3295,3512,8954,9592,005CV (%)4,301 (%)4,088 (%)2,406 (%)4,166 (%)1,879 (%)range111,5055117,8055108,324107,12796,07510% BBrange136,2845143,9845132,396130,933117,42510% BArange99,116104,71696,28895,22485,420% BBrange148,674157,074144,432142,836128,120% BA86Perhitungan :( )( )Range 10 % :Range 20 % :87Lampiran 2. Data hasil folding enduranceFormulaFormula 1Formula 2Formula 3Formula 4Formula 5patch(kontrol)(10:0)(9:1)(8:2)(7:3)R 1>300>300>300>300>300R 2>300>300>300>300>300R 3>300>300>300>300>30088Lampiran 3. Data hasil surface pHFormulaFormula 1Formula 2Formula 3Formula 4Formula 5patch(kontrol)(10:0)(9:1)(8:2)(7:3)R 16-76-76-76-76-7R 26-76-76-76-76-7R 36-76-76-76-76-7total6,56,56,56,56,589Lampiran 4. Data hasil swelling index1.Formula 1 (kontrol)WADAHWADAH+060120180KOSONGPATCHMENITMENITMENITMENIT13,577213,69390,11670,31820,35090,382113,894514,00740,11290,27530,28710,371415,370715,48370,1130,26110,30020,3643% swelling% swelling% swelling(60 menit)(120 menit)(180 menit)172,665200,686227,421143,844154,296228,964131,062165,664222,389Rata rata149,190173,548226,2582.Formula 2 (10:0)WADAHWADAH+060120180KOSONGPATCHMENITMENITMENITMENIT14,257714,38220,12450,24260,26480,303815,901216,02820,12700,24770,26220,296413,248113,37490,12680,24580,27240,2881% swelling% swelling% swelling(60 menit)(120 menit)(180 menit)94,859112,691144,01695,039106,457133,38693,849114,826127,208Rata-rata94,582111,325134,870903.Formula 3 (9:1)WADAHWADAH+060120180KOSONGPATCHMENITMENITMENITMENIT16,511916,63420,12230,29410,3260,375213,376113,50210,12600,30420,33720,383814,521914,64710,12520,299890,33620,3830% swelling% swelling% swelling(60 menit)(120 menit)(180 menit)140,474166,558206,787141,429167,619204,603139,529168,530205,911Rata-rata140,477167,569205,7674.Formula 4 (8:2)WADAHWADAH+060120180KOSONGPATCHMENITMENITMENITMENIT13,736213,84500,10880,36680,41040,458114,498114,60280,10470,31240,33550,408713,743613,85020,10660,37910,42050,4813% swelling% swelling% swelling(60 menit)(120 menit)(180 menit)237,132277,206321,048198,376220,439290,353255,629294,465351,501Rata-rata230,379264,037320,9675.Formula 5 (7:3)WADAHWADAH+060120180KOSONGPATCHMENITMENITMENITMENIT13,784113,90760,12350,35650,39720,428113,745013,87210,12710,36420,43260,474615,385715,50680,12110,29260,34700,458091% swelling% swelling% swelling(60 menit)(120 menit)(180 menit)188,664221,619246,640186,546240,362273,407141,618186,540278,200Rata-rata172,276216,174266,082Perhitungan :92Lampiran 5. Data kurva bakukonsentrasi (ppm)absorbansi (y)slope (b)Intersep (a)320,2130,0067875-0,0022400,272480,322560,381640,43Berdasarkan data diatas, dengan regresi linier diperoleh persamaan :93Lampiran 6. Data hasil keseragaman kadar1. Formula 1 (kontrol)bobotkadar tiapXX%kadarpatch teoritisabsorbansipatch(ppm)(mg/ml)kadar(mg)(mg)126,88,187247780,06710,1950,01012,4531,020136,18,7877320420,07411,2270,01112,7751,123129,38,3486682810,0710,6370,01112,7411,064Rata-rata12,6561,069SD0,052CV (%)4,8662.Formula 2 (10:0)bobotkadar tiapXX%kadarpatch teoritisabsorbansipatch(ppm)(mg/ml)kadar(mg)(mg)138,18,4403529550,52477,5250,07891,8507,7521227,456358150,53679,2930,079106,3437,929129,37,9025172850,51476,0520,07696,2377,605rata-rata98,1437,762SD0,162CV (%)2,0913.Formula 3 (9:1)bobotkadar tiapXX%kadarpatch teoritisabsorbansipatch(ppm)(mg/ml)kadar(mg)(mg)112,67,4842140250,51876,6410,077102,4037,664113,77,5573280160,54680,7660,081106,8718,077119,47,9361914260,55381,7970,082103,0698,180rata-rata104,1157,973SD0,273CV (%)3,425944.Formula 4 (8:2)bobotkadar tiapXX%kadarpatch teoritisabsorbansipatch(ppm)(mg/ml)kadar(mg)(mg)113,67,6350499870,53679,2930,079103,8547,929112,17,5342350670,51876,6410,077101,7247,664114,97,7224229190,56783,8600,084108,5938,386rata-rata104,7237,993SD0,365CV (%)4,5665.Formula 5 (7:3)bobotkadar tiapXX%kadarpatch teoritisabsorbansipatch(ppm)(mg/ml)kadar(mg)(mg)106,67,9887587820,53579,1450,07999,0717,915112,58,4309133490,56783,8600,08499,4678,386112,28,4084309130,54180,0290,08095,1788,003rata-rata97,9058,101SD0,250CV (%)3,086Perhitungan :( )( )()95( )( )96Lampiran 7. Data hasil disolusiREPLIKASI 11.Formula 1 (kontrol)waktuAbsFPdosisXXkadar xfaktorkadar% kadar(menit)(mg)(ppm)(mg/250ml)fpkoreksikoreksiterdisolusi50,00917,7741,6500,4130,4130,0000,4135,306100,01117,7741,9450,4860,4860,0080,4946,360150,01017,7741,7970,4490,4490,0100,4595,905300,00817,7741,5030,3760,3760,0090,3854,948450,00917,7741,6500,4130,4130,0080,4205,403600,00917,7741,6500,4130,4130,0080,4215,4131200,01217,7742,0920,5230,5230,0080,5316,8341800,01317,7742,2390,5600,5600,0100,5707,3362400,01317,7742,2390,5600,5600,0110,5717,3463000,01417,7742,3870,5970,5970,0110,6087,8193600,01017,7741,7970,4490,4490,0120,4615,9344200,01117,7741,9450,4860,4860,0090,4956,3704800,00817,7741,5030,3760,3760,0100,3854,9582.Formula 2 (10:0)waktuAbsFPdosisX (ppm)Xkadar xfaktorkadar% kadar(menit)(mg)(mg/250ml)fpkoreksikoreksiterdisolusi50,10617,00915,9413,9853,9850,0003,98556,858100,10617,00915,9413,9853,9850,0804,06557,995150,10717,00916,0884,0224,0220,0804,10258,520300,13217,00919,7724,9434,9430,0805,02371,668450,14617,00921,8345,4595,4590,0995,55779,288600,16117,00924,0446,0116,0110,1096,12087,3171200,17117,00925,5176,3796,3790,1206,50092,7301800,15417,00923,0135,7535,7530,1285,88183,9012400,15217,00922,7185,6805,6800,1155,79582,6723000,1517,00922,4245,6065,6060,1145,71981,6003600,1517,00922,4245,6065,6060,1125,71881,5794200,1517,00922,4245,6065,6060,1125,71881,5794800,1517,00922,4245,6065,6060,1125,71881,579973.Formula 3 (9:1)waktuAbsFPdosisX (ppm)Xkadar xfaktorkadar% kadar(menit)(mg)(mg/250ml)fpkoreksikoreksiterdisolusi50,10317,64415,4993,8753,8750,0003,87550,687100,10417,64415,6463,9123,9120,0773,98952,183150,12517,64418,7404,6854,6850,0784,76362,311300,15117,64422,5715,6435,6430,0945,73675,041450,16617,64424,7816,1956,1950,1136,30882,518600,16817,64425,0766,2696,2690,1246,39383,6271200,18117,64426,9916,7486,7480,1256,87389,9101800,18617,64427,7276,9326,9320,1357,06792,4442400,19617,64429,2017,3007,3000,1397,43997,3103000,1917,64428,3177,0797,0790,1467,22594,5163600,18417,64427,4336,8586,8580,1427,00091,5674200,17417,64425,9596,4906,4900,1376,62786,6914800,17017,64425,3706,3436,3430,1306,47284,6674.Formula 4 (8:2)waktuAbsFPdosisX (ppm)Xkadar xfaktorkadar% kadar(menit)(mg)(mg/250ml)fpkoreksikoreksiterdisolusi50,02117,82983,41800,85450,85450,00000,854510,9136100,03917,82986,07001,51751,51750,01711,534619,5992150,06417,82989,75322,43832,43830,03032,468731,5289300,15717,829823,45495,86375,86370,04885,912575,5124450,18917,829828,16947,04247,04240,11737,159691,4405600,20217,829830,08477,52127,52120,14087,662097,85701200,20817,829830,96877,74227,74220,15047,8926100,80171800,20717,829830,82147,70537,70530,15487,8602100,38782400,20617,829830,67407,66857,66850,15417,822699,90793000,20617,829830,67407,66857,66850,15347,821999,89853600,20617,829830,67407,66857,66850,15347,821999,89854200,20617,829830,67407,66857,66850,15347,821999,89854800,20617,829830,67407,66857,66850,15347,821999,8985985. Formula 5 (7:3)waktuAbsFPdosisX (ppm)Xkadar xfaktorkadar% kadar(menit)(mg)(mg/250ml)fpkoreksikoreksiterdisolusi50,08218,24912,4053,1013,1010,0003,10137,596100,08918,24913,4363,3593,3590,0623,42141,474150,10918,24916,3834,0964,0960,0674,16350,466300,14618,24921,8345,4595,4590,0825,54067,166450,16618,24924,7816,1956,1950,1096,30476,426600,17418,24925,9596,4906,4900,1246,61480,1771200,18418,24927,4336,8586,8580,1306,98884,7131800,18818,24928,0227,0067,0060,1377,14386,5892400,18918,24928,1697,0427,0420,1407,18287,0713000,1918,24928,3177,0797,0790,1417,22087,5263600,18918,24928,1697,0427,0420,1427,18487,0894200,19518,24929,0537,2637,2630,1417,40489,7594800,20118,24929,9377,4847,4840,1457,63092,492REPLIKASI 21. Formula 1 (kontrol)waktuAbsFPdosisXXkadar xfaktorkadar% kadar(menit)(mg)(ppm)(mg/250ml)fpkoreksikoreksiterdisolusi50,0118,0771,7970,4490,4490,0000,4495,563100,00418,0770,9130,2280,2280,0090,2372,938150,00918,0771,6500,4130,4130,0050,4175,164300,01118,0771,9450,4860,4860,0080,4946,121450,0118,0771,7970,4490,4490,0100,4595,683600,01018,0771,7970,4490,4490,0090,4585,6741200,01118,0771,9450,4860,4860,0090,4956,1301800,00718,0771,3550,3390,3390,0100,3494,3152400,00418,0770,9130,2280,2280,0070,2352,9113000,00618,0771,2080,3020,3020,0050,3073,7963600,00518,0771,0610,2650,2650,0060,2713,3584200,01318,0772,2390,5600,5600,0050,5656,9974800,00918,0771,6500,4130,4130,0110,4245,246992.Formula 2 (10:0)waktuAbsFPdosisX (ppm)Xkadar xfaktorkadar% kadar(menit)(mg)(mg/250ml)fpkoreksikoreksiterdisolusi50,09417,19314,1733,5433,5430,0003,54349,260100,10217,19315,3523,8383,8380,0713,90954,342150,10417,19315,6463,9123,9120,0773,98855,448300,11117,19316,6784,1694,1690,0784,24859,053450,12317,19318,4464,6114,6110,0834,69565,269600,16017,19323,8975,9745,9740,0926,06684,3381200,17217,19325,6656,4166,4160,1196,53690,8621800,15717,19323,4555,8645,8640,1285,99283,3042400,15417,19323,0135,7535,7530,1175,87081,6143000,15117,19322,5715,6435,6430,1155,75880,0473600,14817,19322,1295,5325,5320,1135,64578,4804200,14817,19322,1295,5325,5320,1115,64378,4494800,14817,19322,1295,5325,5320,1115,64378,4493.Formula 3 (9:1)waktuAbsFPdosisX (ppm)Xkadar xfaktorkadar% kadar(menit)(mg)(mg/250ml)fpkoreksikoreksiterdisolusi50,10517,81015,7943,9483,9480,0003,94850,556100,10717,81016,0884,0224,0220,0794,10152,510150,11817,81017,7094,4274,4270,0804,50857,717300,14917,81022,2765,5695,5690,0895,65872,440450,17117,81025,5176,3796,3790,1116,49183,108600,18617,81027,7276,9326,9320,1287,05990,3891200,19017,81028,3177,0797,0790,1397,21892,4171800,19217,81028,6117,1537,1530,1427,29493,3982400,19617,81029,2017,3007,3000,1437,44395,3033000,18517,81027,5806,8956,8950,1467,04190,1543600,18717,81027,8756,9696,9690,1387,10790,9934200,17617,81026,2546,5646,5640,1396,70385,8244800,17117,81025,5176,3796,3790,1316,51183,3621004.Formula 4 (8:2)waktuAbsFPdosisX (ppm)Xkadar xfaktorkadar% kadar(menit)(mg)(mg/250ml)fpkoreksikoreksiterdisolusi50,01818,3202,9760,7440,7440,0000,7448,942100,03418,3205,3331,3331,3330,0151,34816,204150,07318,32011,0792,7702,7700,0272,79633,611300,15718,32023,4555,8645,8640,0555,91971,143450,18318,32027,2856,8216,8210,1176,93983,397600,20618,32030,6747,6697,6690,1367,80593,8091200,20418,32030,3797,5957,5950,1537,74893,1271800,20918,32031,1167,7797,7790,1527,93195,3232400,20818,32030,9697,7427,7420,1567,89894,9253000,20818,32030,9697,7427,7420,1557,89794,9163600,20718,32030,8217,7057,7050,1557,86094,4734200,20718,32030,8217,7057,7050,1547,85994,4644800,20618,32030,6747,6697,6690,1547,82394,0225.Formula 5 (7:3)waktuAbsFPdosisX (ppm)Xkadar xfaktorkadar% kadar(menit)(mg)(mg/250ml)fpkoreksikoreksiterdisolusi50,07917,96111,9632,9912,9910,0002,99137,570100,08417,96112,7003,1753,1750,0603,23540,635150,12517,96118,7404,6854,6850,0634,74959,651300,13717,96120,5085,1275,1270,0945,22165,583450,16817,96125,0766,2696,2690,1036,37180,037600,18117,96126,9916,7486,7480,1256,87386,3391200,18817,96128,0227,0067,0060,1357,14089,6981800,1917,96128,3177,0797,0790,1407,21990,6882400,19017,96128,3177,0797,0790,1427,22190,7063000,18917,96128,1697,0427,0420,1427,18490,2443600,19017,96128,3177,0797,0790,1417,22090,6974200,19917,96129,6437,4117,4110,1427,55294,8704800,19717,96129,3487,3377,3370,1487,48594,028101REPLIKASI 31. Formula 1 (kontrol)waktuAbsFPdosisX (ppm)Xkadar xfaktorkadar% kadar(menit)(mg)(mg/250ml)fpkoreksikoreksiterdisolusi50,00717,7221,3550,3390,3390,0000,3394,388100,01217,7222,0920,5230,5230,0070,5306,861150,00817,7221,5030,3760,3760,0100,3865,000300,00817,7221,5030,3760,3760,0080,3834,962450,00817,7221,5030,3760,3760,0080,3834,962600,00817,7221,5030,3760,3760,0080,3834,9621200,00417,7220,9130,2280,2280,0080,2363,0541800,00617,7221,2080,3020,3020,0050,3073,9702400,01117,7221,9450,4860,4860,0060,4926,3743000,00817,7221,5030,3760,3760,0100,3854,9913600,01217,7222,0920,5230,5230,0080,5316,8704200,00317,7220,7660,1920,1920,0100,2022,6164800,00817,7221,5030,3760,3760,0040,3804,9152. Formula 2 (10:0)waktuAbsFPdosisX (ppm)Xkadar xfaktorkadar% kadar(menit)(mg)(mg/250ml)fpkoreksikoreksiterdisolusi50,10317,38315,4993,8753,8750,0003,87552,484100,10917,38316,3834,0964,0960,0774,17356,527150,11517,38317,2674,3174,3170,0824,39959,580300,12117,38318,1514,5384,5380,0864,62462,633450,14217,38321,2455,3115,3110,0915,40273,170600,16517,38324,6346,1586,1580,1066,26584,8541200,17717,38326,4016,6006,6000,1236,72491,0711800,16317,38324,3396,0856,0850,1326,21784,2062400,15317,38322,8665,7165,7160,1225,83879,0773000,14417,38321,5405,3855,3850,1145,49974,4873600,14417,38321,5405,3855,3850,1085,49374,3974200,14317,38321,3925,3485,3480,1085,45673,8994800,14317,38321,3925,3485,3480,1075,45573,8891023.Formula 3 (9:1)waktuAbsFPdosisX (ppm)Xkadar xfaktorkadar% kadar(menit)(mg)(mg/250ml)fpkoreksikoreksiterdisolusi50,118,22115,0573,7643,7640,0003,76445,790100,10518,22115,7943,9483,9480,0754,02448,946150,13118,22119,6244,9064,9060,0794,98560,640300,15418,22123,0135,7535,7530,0985,85171,178450,16918,22125,2236,3066,3060,1156,42178,104600,18118,22126,9916,7486,7480,1266,87483,6151200,18918,22128,1697,0427,0420,1357,17787,3071800,19718,22129,3487,3377,3370,1417,47890,9632400,19618,22129,2017,3007,3000,1477,44790,5873000,19418,22128,9067,2277,2270,1467,37389,6823600,18618,22127,7276,9326,9320,1457,07686,0804200,18418,22127,4336,8586,8580,1396,99785,1124800,17718,22126,4016,6006,6000,1376,73881,9584.Formula 4 (8:2)waktuAbsFPdosisX (ppm)Xkadar xfaktorkadar% kadar(menit)(mg)(mg/250ml)fpkoreksikoreksiterdisolusi50,02618,3944,1551,0391,0390,0001,03912,374100,04418,3946,8071,7021,7020,0211,72220,520150,0618,3949,1642,2912,2910,0342,32527,699300,14918,39422,2765,5695,5690,0465,61566,892450,18518,39427,5806,8956,8950,1117,00683,470600,20518,39430,5277,6327,6320,1387,77092,5621200,2118,39431,2637,8167,8160,1537,96894,9321800,20918,39431,1167,7797,7790,1567,93594,5372400,20718,39430,8217,7057,7050,1567,86193,6503000,20718,39430,8217,7057,7050,1547,85993,6333600,20718,39430,8217,7057,7050,1547,85993,6334200,20718,39430,8217,7057,7050,1547,85993,6334800,20818,39430,9697,7427,7420,1547,89694,0721035. Formula 5 (7:3)waktuAbsFPdosisX (ppm)Xkadar xfaktorkadar% kadar(menit)(mg)(mg/250ml)fpkoreksikoreksiterdisolusi50,07718,37811,6692,9172,9170,0002,91734,819100,09318,37814,0263,5063,5060,0583,56542,549150,12118,37818,1514,5384,5380,0704,60855,000300,14818,37822,1295,5325,5320,0915,62367,116450,17418,37825,9596,4906,4900,1116,60178,784600,17418,37825,9596,4906,4900,1306,62079,0131200,1818,37826,8436,7116,7110,1306,84181,6501800,18318,37827,2856,8216,8210,1346,95683,0222400,19418,37828,9067,2277,2270,1367,36387,8843000,19518,37829,0537,2637,2630,1457,40888,4213600,19918,37829,6437,4117,4110,1457,55690,1884200,19318,37828,7597,1907,1900,1487,33887,5854800,19918,37829,6437,4117,4110,1447,55490,170WaktuRata-rata kadar terdisolusi (%)(menit)KONTROLF 10:0F 9:1F 8:2F 7:355,08652,86749,01110,74336,662105,38656,28851,21318,77541,553155,35657,84960,22230,94655,039305,34464,45172,88671,18366,621455,35072,57681,24486,10378,416605,35085,50385,87794,74381,8431205,34091,55489,87896,28785,3541805,20783,80492,26896,74986,7662405,54481,12194,40096,16188,5543005,53578,71191,45096,14988,7303605,38778,15289,54796,00289,3254205,32777,97685,87695,99990,7384805,03977,97283,32995,99792,230104Perhitungan disolusi :( )( )( )( )()105WaktuLog kadar terdisolusi (%)(menit)kontrolf 10:0f 9:1f 8:2f 7:350,70411,72241,68981,02731,5639100,70261,75031,70921,27141,6185150,72771,76211,77951,48921,7397300,72571,80781,86251,85181,8236450,72761,85941,90961,93461,8943600,72771,93191,93361,97641,91271200,70241,96171,95351,98331,93091800,69981,92331,96501,98551,93812400,71151,90911,97481,98281,94713000,72351,89571,96111,98281,94803600,71211,89261,95191,98211,95094200,68891,89161,93391,98211,95754800,70221,89161,92081,98211,9648Akar waktuKadar terdisolusi (%)(menit )KONTROLF 10:0F 9:1F 8:2F 7:32,2365,08652,86749,01110,74336,6623,1625,38656,28851,21318,77541,5533,8735,35657,84960,22230,94655,0395,4775,34464,45172,88671,18366,6216,7085,35072,57681,24486,10378,4167,7465,35085,50385,87794,74381,84310,9545,34091,55489,87896,28785,35413,4165,20783,80492,26896,74986,76615,4925,54481,12194,40096,16188,55417,3215,53578,71191,45096,14988,73018,9745,38778,15289,54796,00289,32520,4945,32777,97685,87695,99990,73821,9095,03977,97283,32995,99792,230106LogLog kadar terdisolusi (%)waktu(menit)kontrolf 10:0f 9:1f 8:2f 7:30,6990,7041,7221,6901,0271,5641,0000,7031,7501,7091,2711,6191,1760,7281,7621,7801,4891,7401,4770,7261,8081,8631,8521,8241,6530,7281,8591,9101,9351,8941,7780,7281,9321,9341,9761,9132,0790,7021,9621,9541,9831,9312,2550,7001,9231,9651,9851,9382,3800,7111,9091,9751,9831,9472,4770,7241,8961,9611,9831,9482,5560,7121,8931,9521,9821,9512,6230,6891,8921,9341,9821,9582,6810,7021,8921,9211,9821,965107Nilai AUC (area under curves) 1. Formula 1 (kontrol)REPLIKASIREPLIKASIREPLIKASIwaktu (menit)123513,2660913,9076610,970041029,1664521,2536428,121451530,6636320,2550229,652493081,4016984,6360874,720274577,6350788,5347974,434096081,1174285,1832774,43409120367,39496354,13914240,50140180425,10247313,37374210,73920240440,45323216,79532310,32807300454,95118201,20050340,94879360412,59444214,60657355,82988420369,10060310,63781284,57233480339,82044367,27162225,90647AUC total3122,667672291,795152261,158592. Formula 2 (10:0)REPLIKASIREPLIKASIREPLIKASIwaktu (menit)1235142,14428123,14984131,2097110287,13144259,00384272,5270615291,28804274,47309290,2678130976,41295858,75126916,60211451132,16734932,410741018,52661601249,534901122,051251185,182901205401,398445255,984125277,743531805298,928445224,953435258,286582404997,193714947,520654898,482613004928,144704849,820064606,927653604895,354304755,806304466,538244204894,723724707,877714448,877324804894,723724706,956014433,61109AUC total39389,1459838018,7583037204,783241083.Formula 3 (9:1)REPLIKASIREPLIKASIREPLIKASIwaktu (menit)1235126,71865126,38967114,4747510257,17621257,66514236,8395215286,23477275,56720273,96429301030,13586976,17625988,63172451181,692321166,609641119,61682601246,087561301,228781212,899181205206,083765484,198575127,680251805470,602915574,463435348,116952405692,625545661,049785446,506993005754,780315563,710875408,064983605582,481505434,397275272,845884205347,738825304,517745135,745014805140,748985075,601535012,08539AUC total42323,1071942201,5758740697,471734.Formula 4 (8:2)REPLIKASIREPLIKASIREPLIKASIwaktu (menit)123527,2838922,3561430,935411076,2819862,8672482,2355415127,82030124,53921120,5471830802,80954785,65681709,43454451252,146921159,048651127,72079601419,731131329,043861320,244361205959,760395608,089125624,821241806035,684865653,509715684,059262406008,871395707,430075645,620363005994,194545695,211675618,502513605993,912295681,665175617,975954205993,912295668,118685617,975954805993,912295654,572185631,13996AUC total45686,3218143152,1085142831,213061095. Formula 5 (7:3)REPLIKASIREPLIKASIREPLIKASIwaktu (menit)123593,9900793,9247387,0473510197,67384195,51150193,4209615229,84926250,71426243,8732530882,23857939,25195915,86997451076,938671092,145691094,25108601174,523131247,815521183,474611204946,708555281,086974819,890681805139,064485411,563694940,174292405209,791455441,823195127,194193005237,921495428,497905289,155013605238,457305428,220295358,265334205305,433605567,025325333,206244805467,516245666,964945332,67868AUC total40200,1066742044,5459639918,50166Perhitungan :()( )() ( )Nilai koefisien korelasi orde nolFormula PatchNilai rkontrol0,065Formula 10:00,504Formula 9:10,609Formula 8:20,639Formula 7:30,741110Nilai koefisien korelasi orde satuFormula PatchNilai rkontrol0,457Formula 10:00,533Formula 9:10,604Formula 8:20,582Formula 7:30,690Nilai koefisien korelasi orde satuFormula PatchNilai rkontrol0,042Formula 10:00,649Formula 9:10,751Formula 8:20,764Formula 7:30,849Nilai koefisien korelasi higuchiFormula PatchNilai rkontrol0,042Formula 10:00,649Formula 9:10,751Formula 8:20,764Formula 7:30,849Nilai koefisien korelasi dan nilai eksponensial difusi korsmeyer-peppasformularnkontrol0,276-0,0054610:00,8260,094429:10,890,131878:20,8650,420877:30,9280,18918111Lampiran 8. Data statistik swelling indexDescriptive StatisticsStd.MinimuMaximuNMeanDeviationmmswelling15191,567363,1356394,58320,97indexOne-Sample Kolmogorov-Smirnov TestswellingindexN15Normal Parametersa,bMean191,5673Std. Deviation63,13563Most ExtremeAbsolute,146DifferencesPositive,146Negative-,074Kolmogorov-Smirnov Z,564Asymp. Sig. (2-tailed),908Test distribution is Normal. Calculated from data. Test of Homogeneity of Variancesswelling indexLeveneStatisticdf1df2Sig.,481410,749ANOVAswelling indexSum ofMeanSquaresdfSquareFSig.Between41131,538410282,8857,008,006GroupsWithin Groups14673,965101467,396Total55805,50314112Multiple Comparisonsswelling index Scheffe(I) formula patch(J) formula patchMean95% Confidence IntervalDifferenceLowerUpper(I-J)Std. ErrorSig.BoundBoundkontrol10:069,4100031,27722,358-47,2511186,0711dimension39:111,7266731,27722,997-104,9344128,38778:2-88,7966731,27722,168-205,457727,86447:3-35,1766731,27722,861-151,837781,484410:0kontrol-69,4100031,27722,358-186,071147,2511dimension39:1-57,6833331,27722,525-174,344458,97778:2-158,20667*31,27722,008-274,8677-41,54567:3-104,5866731,27722,085-221,247712,07449:1kontrol-11,7266731,27722,997-128,3877104,9344dimensiodimension310:057,6833331,27722,525-58,9777174,3444n28:2-100,5233331,27722,102-217,184416,13777:3-46,9033331,27722,696-163,564469,75778:2kontrol88,7966731,27722,168-27,8644205,4577dimension310:0158,20667*31,27722,00841,5456274,86779:1100,5233331,27722,102-16,1377217,18447:353,6200031,27722,589-63,0411170,28117:3kontrol35,1766731,27722,861-81,4844151,8377dimension310:0104,5866731,27722,085-12,0744221,24779:146,9033331,27722,696-69,7577163,56448:2-53,6200031,27722,589-170,281163,0411*. The mean difference is significant at the 0.05 level.113Lampiran 9. Data statistik disolusi efisiensiDescriptive StatisticsStd.MinimuMaximuNMeanDeviationmmDE 4801569,44822833,67288894,728697,1634(%)One-Sample Kolmogorov-Smirnov TestDE 480(%)N15Normal Parametersa,bMean69,448228Std. Deviation33,6728889Most ExtremeAbsolute,371DifferencesPositive,205Negative-,371Kolmogorov-Smirnov Z1,435Asymp. Sig. (2-tailed),033Test distribution is Normal. Calculated from data. Test of Homogeneity of VariancesDE 480 (%)LeveneStatisticdf1df2Sig.2,804410,085ANOVADE 480 (%)Sum ofMeanSquaresdfSquareFSig.Between15738,47143934,618290,127,000GroupsWithin Groups135,6171013,562Total15874,08814114Multiple ComparisonsDE 480 (%)Scheffe(I) formula patch(J) formula patchMean95% Confidence IntervalDifferenceLowerUpper(I-J)Std. ErrorSig.BoundBoundkontrolformula 10:0-71,9380464*3,0068477,000-83,153306-60,722787dimension3formula 9:1-82,5485355*3,0068477,000-93,763795-71,333276formula 8:2-87,0842173*3,0068477,000-98,299477-75,868958formula 7:3-78,4988347*3,0068477,000-89,714094-67,283575formula 10:0kontrol71,9380464*3,0068477,00060,72278783,153306dimension3formula 9:1-10,61048913,0068477,066-21,825748,604770formula 8:2-15,1461709*3,0068477,008-26,361430-3,930912formula 7:3-6,56078823,0068477,373-17,7760484,654471formula 9:1kontrol82,5485355*3,0068477,00071,33327693,763795dimension2dimension3formula 10:010,61048913,0068477,066-,60477021,825748formula 8:2-4,53568183,0068477,691-15,7509416,679578formula 7:34,04970083,0068477,768-7,16555815,264960formula 8:2kontrol87,0842173*3,0068477,00075,86895898,299477dimension3formula 10:015,1461709*3,0068477,0083,93091226,361430formula 9:14,53568183,0068477,691-6,67957815,750941formula 7:38,58538263,0068477,165-2,62987719,800642formula 7:3kontrol78,4988347*3,0068477,00067,28357589,714094dimension3formula 10:06,56078823,0068477,373-4,65447117,776048formula 9:1-4,04970083,0068477,768-15,2649607,165558formula 8:2-8,58538263,0068477,165-19,8006422,629877*. The mean difference is significant at the 0.05 level.115Lampiran 10. Surat keterangan permintaan bahan116117Lampiran 11. Cetakan patch118Lampiran 12. Alat disolusi dan spektrofotometerAlat disolusiSpektrofotometer